Cargando…
MRGPRX2 and Adverse Drug Reactions
Many adverse reactions to therapeutic drugs appear to be allergic in nature, and are thought to be triggered by patient-specific Immunoglobulin E (IgE) antibodies that recognize the drug molecules and form complexes with them that activate mast cells. However, in recent years another mechanism has b...
Autor principal: | McNeil, Benjamin D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377365/ https://www.ncbi.nlm.nih.gov/pubmed/34421893 http://dx.doi.org/10.3389/fimmu.2021.676354 |
Ejemplares similares
-
Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions
por: Porebski, Grzegorz, et al.
Publicado: (2018) -
Biological screening of a unique drug library targeting MRGPRX2
por: Yang, Fan, et al.
Publicado: (2022) -
Antibody or Anybody? Considering the Role of MRGPRX2 in Acute Drug-Induced Anaphylaxis and as a Therapeutic Target
por: Mackay, Graham A., et al.
Publicado: (2021) -
Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones
por: Elst, Jessy, et al.
Publicado: (2021) -
MRGPRX2 signaling involves the Lysyl-tRNA synthetase and MITF pathway
por: Guo, Yanru, et al.
Publicado: (2023)